| TORYX | VIVIX | TORYX / VIVIX | |
| Total Expense Ratio | 0.95 | 0.04 | 2,375% |
| Annual Report Gross Expense Ratio | 0.97 | 0.04 | 2,425% |
| Fund Existence | 35 years | 27 years | - |
| Gain YTD | 15.645 | 11.991 | 130% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2000 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 359M | 208B | 0% |
| Annual Yield % from dividends | 2.11 | 2.10 | 101% |
| Returns for 1 year | 3.29 | 6.69 | 49% |
| Returns for 3 years | 27.48 | 33.49 | 82% |
| Returns for 5 years | 41.52 | 66.36 | 63% |
| Returns for 10 years | 44.96 | 134.98 | 33% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MNCSX | 13.56 | 0.12 | +0.89% |
| Mercer Non-US Core Equity I | |||
| TCMPX | 18.16 | 0.10 | +0.55% |
| AMG TimesSquare International SmallCap N | |||
| RIRBX | 80.75 | 0.40 | +0.50% |
| American Funds Capital Income Bldr R2 | |||
| AOBLX | 12.95 | 0.04 | +0.31% |
| Victory Pioneer Balanced A | |||
| FPHAX | 30.52 | N/A | N/A |
| Fidelity Select Pharmaceuticals Port | |||